Lonoctocog alfa, Recombinant Factor VIII

Specification

• Cat#: THP-0216
• Product Name: Lonoctocog alfa, Recombinant Factor VIII
• Cas No: 1388129-63-2
• Description: Lonoctocog alfa is a recombinant Factor VIII used to treat hemophilia A to control bleeding.
• Sequences: Not Available
• Species: Human
• Molecular Weight: Not Available
• Purity: >99% by SDS-Page and HPLC analysis
• Formula: Not Available
• Endotoxin: <0.001 EU per 1 μg of the peptide by the LAL method
• Biological Activity: 250IU-2500IU
• Application: For the treatment of hemophilia A, von Willebrand disease and Factor XIII deficiency.

Pharmaceutical Information

• Pharmaceutical Application: Lonoctocog alfa
• Targets: Target 1. Coagulation factor X; Target 2. Phytanoyl-CoA dioxygenase, peroxisomal; Target 3. Coagulation factor IX; Target 4. Asialoglycoprotein receptor 2; Target 5. 78 kDa glucose-regulated protein; Target 6. Calreticulin; Target 7. Calnexin; Target 8. Protein ERGIC-53; Target 9. Prolow-density lipoprotein receptor-related protein 1; Target 10. Multiple coagulation factor deficiency protein 2; Target 11. von Willebrand factor.